Reuters looks at influencers pushing dietary supplements to people on weight loss drugs, turning TikTok into a sales engine for so-called GLP-1 products.
Recap by typeshit. Post by Reuters on X.
The FDA had warned the Cary, North Carolina pharmacy in December 2025 about sterile production problems. Check your vial's lot number and beyond-use date.
Bazaar looks at how the beauty business is reacting to GLP-1 side effects, from 'Ozempic face' to worries about collagen loss and loose skin.
Dr. Zheng says the drugs have been associated with NAION, an eye condition that can cause permanent vision loss, and points to patients with risk factors.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
12:50
Alex Wallace, who bills himself as a peptide expert, gives his response to what Dr. Mike has said about peptides. Details beyond the title are thin.
The two drugs brought in $14.9 billion of Lilly's $23.0 billion fiscal Q2 revenue while US prices fell 9%, Trefis says. The Q3 report is expected around October 29.
Loading…